<code id='A36D95DE82'></code><style id='A36D95DE82'></style>
    • <acronym id='A36D95DE82'></acronym>
      <center id='A36D95DE82'><center id='A36D95DE82'><tfoot id='A36D95DE82'></tfoot></center><abbr id='A36D95DE82'><dir id='A36D95DE82'><tfoot id='A36D95DE82'></tfoot><noframes id='A36D95DE82'>

    • <optgroup id='A36D95DE82'><strike id='A36D95DE82'><sup id='A36D95DE82'></sup></strike><code id='A36D95DE82'></code></optgroup>
        1. <b id='A36D95DE82'><label id='A36D95DE82'><select id='A36D95DE82'><dt id='A36D95DE82'><span id='A36D95DE82'></span></dt></select></label></b><u id='A36D95DE82'></u>
          <i id='A36D95DE82'><strike id='A36D95DE82'><tt id='A36D95DE82'><pre id='A36D95DE82'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:1
          Lee Klafczynski for STAT

          WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by.

          Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

          advertisement

          Politicians have been well aware of the problem for years. At the request of a large bipartisan group of lawmakers, a task force chaired by the Food and Drug Administration in 2019 reported on the root causes of drug shortages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Cassava reveals details — and problems — with Alzheimer's study
          Cassava reveals details — and problems — with Alzheimer's study

          MollyFerguson/STATCassavaScienceshaslongclaimeditsexperimentaldrug,calledsimufilam,slowsthecognitive

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          The FDA weighs the risks of candy

          AdobeWASHINGTON—M&Ms,Reese’s,gummybears,andevencottoncandymadeanappearanceattheFoodandDrugAdmini